Medical Countermeasures UK Opens Moderna mRNA Vaccine Centre in Oxfordshire and Launches £50 Million Life-Sciences FundGlobal Biodefense StaffSeptember 29, 2025
Contracts + Grants U.S. Expands Investments in Biodefense Preparedness Through New Medical Countermeasure ContractsGlobal Biodefense StaffSeptember 23, 2025
Pathogens New Study Reveals Key to Marburg and Ebola Virus Assembly, Opening Door to Broad-Spectrum AntiviralsGlobal Biodefense StaffSeptember 23, 2025
First Lethal Hamster Model for SARS-CoV-2 Developed by USAMRIID Scientists Medical Countermeasures February 4, 2022 …
Complete Protection Against Yersinia pestis by Immunization with Inhalable rF1-V10 Fusion Protein Medical Countermeasures February 2, 2022 …
Elusys Therapeutics Finalizes HHS Contract to Deliver Inhalation Anthrax Treatment Medical Countermeasures January 31, 2022 …
Three Doses of mRNA COVID-19 Vaccines Effective Against Hospitalizations for Omicron and Delta Medical Countermeasures January 21, 2022 …
Preclinical Studies Support Army’s Pan-Coronavirus Vaccine Development Strategy Medical Countermeasures December 16, 2021 …
Biodefense and Countering Disease with Neutralizing Antibodies Medical Countermeasures December 15, 2021 …
Stopping Lethal Anthrax Using an Enzyme to Disrupt the Bacterial Capsule Defense + Military December 8, 2021 …
Does AstraZeneca’s COVID Vaccine Give Longer-Lasting Protection Than mRNA Shots? Medical Countermeasures December 4, 2021 …
Why Moderna Won’t Share Rights to the COVID-19 Vaccine with the Government That Paid for Its Development Medical Countermeasures November 18, 2021 …
JPEO-CBRND Seeks Prototype Proposals for Vaccine Acceleration Program Contracts + Grants November 15, 2021 …
Birmingham Biotech and University of Birmingham Partner on Covid-19 Anti-viral Nasal Spray Industry News November 9, 2021 …
Nose Sprays, Needle-Free Patches, Durable Immunity: Towards the Next Generation of COVID Vaccines Medical Countermeasures November 8, 2021 …
Vaccination Offers Higher Protection Than Previous COVID-19 Infection Medical Countermeasures October 29, 2021 …
A Pediatrician Explains How Pfizer’s Covid-19 Vaccine for Ages 5 to 11 Was Tested for Safety and Efficacy Medical Countermeasures October 29, 2021 …
Rwanda and Senegal Will Host Africa’s First COVID-19 Vaccine Manufacturing Plants Industry News October 27, 2021 …
Ivermectin: Misuse Against COVID Risks Undermining Its Use for Other Diseases Medical Countermeasures October 27, 2021 …
Navigating New Federal Rules on ‘Mix-and-Match’ Vaccine Booster Shots Medical Countermeasures October 27, 2021 …
Data Shows Continued Vulnerability of Vaccinated Blood Cancer Patients to COVID-19 Medical Countermeasures October 23, 2021 …
